Re: Reduction in Urinary Oxalate Excretion in Mouse Models of Primary Hyperoxaluria by RNA Interference Inhibition of Liver Lactate Dehydrogenase Activity. - Suppr | 超能文献

Re: Reduction in Urinary Oxalate Excretion in Mouse Models of Primary Hyperoxaluria by RNA Interference Inhibition of Liver Lactate Dehydrogenase Activity.

作者信息

Assimos Dean G

出版信息

J Urol. 2019 Nov;202(5):861-862. doi: 10.1097/JU.0000000000000476. Epub 2019 Oct 9.

DOI:10.1097/JU.0000000000000476

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Re: Reduction in Urinary Oxalate Excretion in Mouse Models of Primary Hyperoxaluria by RNA Interference Inhibition of Liver Lactate Dehydrogenase Activity.

J Urol. 2019 Nov;202(5):861-862. doi: 10.1097/JU.0000000000000476. Epub 2019 Oct 9.

2

Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.通过 RNA 干扰抑制肝乳酸脱氢酶活性减少原发性高草酸尿症小鼠模型中的尿草酸盐排泄。

Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2203-2209. doi: 10.1016/j.bbadis.2019.04.017. Epub 2019 May 2.

3

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.特异性抑制肝乳酸脱氢酶可减少原发性高草酸尿症小鼠模型中的草酸盐生成。

Mol Ther. 2018 Aug 1;26(8):1983-1995. doi: 10.1016/j.ymthe.2018.05.016. Epub 2018 Jun 15.

4

Re: The Effects of the Inactivation of Hydroxyproline Dehydrogenase on Urinary Oxalate and Glycolate Excretion in Mouse Models of Primary Hyperoxaluria.

J Urol. 2020 May;203(5):876. doi: 10.1097/JU.0000000000000776.02. Epub 2020 Feb 12.

5

[Effect of stiripentol on urine oxalate excretion].[司替戊醇对尿草酸排泄的影响]

Nephrol Ther. 2021 Apr;17S:S95-S99. doi: 10.1016/j.nephro.2020.02.001.

6

Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria.治疗性 RNA 干扰：原发性高草酸尿症治疗的新方法。

Br J Clin Pharmacol. 2022 Jun;88(6):2525-2538. doi: 10.1111/bcp.14925. Epub 2021 Jun 11.

7

Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.吡哆胺可降低实验性高草酸尿症中的草酸盐排泄和肾结晶：一种治疗原发性高草酸尿症的潜在疗法。

Urol Res. 2005 Nov;33(5):368-71. doi: 10.1007/s00240-005-0493-3. Epub 2005 Nov 15.

8

Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.原发性高草酸尿症小鼠模型中（13）C5-羟脯氨酸的代谢及其受靶向肝脏乙醇酸氧化酶和羟脯氨酸脱氢酶的RNAi疗法的抑制作用

Biochim Biophys Acta. 2016 Feb;1862(2):233-9. doi: 10.1016/j.bbadis.2015.12.001. Epub 2015 Dec 2.

9

An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.一种靶向乙醇酸氧化酶的研究性RNAi疗法可降低原发性高草酸尿症模型中的草酸盐生成。

J Am Soc Nephrol. 2017 Feb;28(2):494-503. doi: 10.1681/ASN.2016030338. Epub 2016 Jul 18.

10

Re: Plasma Oxalate in Relation to eGFR in Patients with Primary Hyperoxaluria, Enteric Hyperoxaluria and Urinary Stone Disease.关于原发性高草酸尿症、肠道高草酸尿症和尿路结石病患者血浆草酸盐与估算肾小球滤过率的关系

J Urol. 2018 Apr;199(4):887. doi: 10.1016/j.juro.2018.01.035. Epub 2018 Jan 18.